GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,132,000 | -56.3% | 29,813 | -48.0% | 0.05% | -50.5% |
| Q2 2018 | $2,590,000 | +48.1% | 57,313 | +58.3% | 0.10% | +50.0% |
| Q1 2018 | $1,749,000 | +405.5% | 36,213 | +310.9% | 0.07% | +366.7% |
| Q4 2017 | $346,000 | -87.7% | 8,813 | -90.3% | 0.02% | -89.6% |
| Q3 2017 | $2,819,000 | +3.3% | 90,813 | -9.0% | 0.14% | -0.7% |
| Q2 2017 | $2,729,000 | +362.5% | 99,813 | +523.3% | 0.14% | +437.0% |
| Q1 2017 | $590,000 | -43.7% | 16,013 | -74.7% | 0.03% | -48.1% |
| Q2 2016 | $1,048,000 | +17.2% | 63,180 | +12.0% | 0.05% | +30.0% |
| Q1 2016 | $894,000 | +87.0% | 56,400 | +281.1% | 0.04% | +73.9% |
| Q4 2015 | $478,000 | – | 14,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |